Reticuloendothelial system and neuro-endocrine stimulation in shock therapy.
D000818:Animals; D004876:Ergot Alkaloids / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D012157:Mononuclear Phagocyte System / Q000503:physiopathology*; D010587:Phagocytosis; D051381:Rats; D012769:Shock / Q000188:drug therapy* / Q000503:physiopathology*; D012771:Shock, Hemorrhagic / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014667:Vasopressins / Q000627:therapeutic use
D004876:Ergot Alkaloids; D005938:Glucocorticoids; D006633:Histamine Antagonists; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014667:Vasopressins